Serum-soluble interleukin-2 receptor levels in Kawasaki disease

Bianca A. Lang, Earl D. Silverman, Ronald M. Laxer, Vera Rose, David L. Nelson, Laurence A. Rubin

Résultat de recherche: Articleexamen par les pairs

50 Citations (Scopus)
Langue d'origineEnglish
Pages (de-à)592-596
Nombre de pages5
JournalJournal of Pediatrics
Volume116
Numéro de publication4
DOI
Statut de publicationPublished - avr. 1990
Publié à l'externeOui

Note bibliographique

Funding Information:
Recent studies have suggested that immune activation may contribute to the pathogenesis of Kawasaki disease. Abnormalities of immunoregulation include increased numbers of Supported by a fellowship from the Arthritis Society of Canada (Dr. Lang), associateships of The Arthritis Society of Canada (Drs. Silverman, Laxer, and Rubin), and grants from the Canadian Heart Society, the Arthritis Society of Canada, and Baxter Healthcare Corporation, Hyland Division, Glendale, Calif. Submitted for publication July 17, 1989; accepted Oct. 18, 1989. Reprint requests: Earl D. Silverman, MD, Division of Immunology/Rheumatology, The Hospital for Sick Children, 555 University Ave., Toronto, Ontario M5G 1X8, Canada. 9/22/17488

ASJC Scopus Subject Areas

  • Pediatrics, Perinatology, and Child Health

Citer